...
机译:17,486个管状胃肠癌癌中的DNA损伤基因改变和肿瘤突变负担分析:治疗的影响
Massachusetts Gen Hosp Ctr Canc 55 Fruit St Lawrence House 226 Boston MA 02129 USA;
Fdn Med Inc Cambridge MA USA;
Massachusetts Gen Hosp Ctr Canc 55 Fruit St Lawrence House 226 Boston MA 02129 USA;
Massachusetts Gen Hosp Ctr Canc 55 Fruit St Lawrence House 226 Boston MA 02129 USA;
Massachusetts Gen Hosp Ctr Canc 55 Fruit St Lawrence House 226 Boston MA 02129 USA;
Massachusetts Gen Hosp Ctr Canc 55 Fruit St Lawrence House 226 Boston MA 02129 USA;
Massachusetts Gen Hosp Ctr Canc 55 Fruit St Lawrence House 226 Boston MA 02129 USA;
Massachusetts Gen Hosp Ctr Canc 55 Fruit St Lawrence House 226 Boston MA 02129 USA;
Univ Chicago Med Ctr Chicago IL 60637 USA;
City Hope Natl Med Ctr Dept Med Oncol 1500 E Duarte Rd Duarte CA 91010 USA;
City Hope Natl Med Ctr Dept Med Oncol 1500 E Duarte Rd Duarte CA 91010 USA;
Angeles Clin &
Res Inst Los Angeles CA USA;
Fdn Med Inc Cambridge MA USA;
Fdn Med Inc Cambridge MA USA;
Fdn Med Inc Cambridge MA USA;
Fdn Med Inc Cambridge MA USA;
Fdn Med Inc Cambridge MA USA;
DNA damage response; Tumor mutational burden; Poly (ADP-ribose) polymerase; Immunotherapy; Gastrointestinal cancers;
机译:17,486个管状胃肠癌癌中的DNA损伤基因改变和肿瘤突变负担分析:治疗的影响
机译:DNA损伤反应及修复途径改变及其与SCLC血浆突变负担和铂化疗的关系
机译:循环性无细胞肿瘤DNA(cfDNA)的遗传改变和突变图谱,用于胃肠道间质瘤的诊断和靶向治疗
机译:下一代测序对非小细胞肺癌抗蛋白酶激酶抑制剂进行下一代测序检测的低负荷EGFR突变的预测疗效
机译:野生型p53但缺乏p53介导的细胞凋亡的肿瘤中DNA解旋酶基因XPB,XPD,WRN和BLM的突变分析
机译:循环性无细胞肿瘤DNA(cfDNA)的遗传改变和突变图谱用于胃肠道间质瘤的诊断和靶向治疗
机译:P1.04-04 DNA损伤响应基因改变与高肿瘤突变负担和NSCLC中PD-1轴抑制的临床益处相关